Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults

This study has been completed.
Sponsor:
Collaborators:
Vaccine Technologies, Inc.
Siriraj Hospital, Mahidol University
Information provided by (Responsible Party):
International Vaccine Institute
ClinicalTrials.gov Identifier:
NCT00741637
First received: August 25, 2008
Last updated: March 29, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2011
  Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)